n-cyclohexyl-3-aminopropanesulfonic acid cas 1135-40-6
Appearance: White Crystalinel Powder
Assay: 99%min
Packing: 25kg/drum,Foil bag
Capacity: 300MT/year
Sample: Available
related documents:
COA of N-Cyclohexyl-3-aminopropanesulfonic acid(CAPS)
TDS of N-Cyclohexyl-3-aminopropanesulfonic acid(CAPS)
Request for product documents
n-Cyclohexyl-3-aminopropanesulfonic Acid (CAPS) CAS 1135-40-6: Ultimate Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Technical Applications & Usage Scenarios
- 3. Protocol Implementation & Case Studies
- 4. Industry-Specific Implementation Examples
- 5. Verified Client Success Stories
- 6. Expert Consultation & Sample Request
1. Product Specifications & Comparative Analysis
| Parameter | CAPS | HEPES | Tris |
|---|---|---|---|
| CAS Number | 1135-40-6 | 7365-45-9 | 77-86-1 |
| Effective pH Range | 9.7-11.1 | 6.8-8.2 | 7.0-9.0 |
| Temperature Sensitivity | ±0.02 pH/°C | ±0.014 pH/°C | ±0.03 pH/°C |
| Metal Chelation | No | Yes | No |
2. Technical Applications & Usage Scenarios
Biochemical Applications
CAPS buffer demonstrates exceptional performance in:
- Western blot transfer protocols (10-12% gel systems)
- Enzyme kinetics studies above pH 9.5
- High-resolution chromatography (HPLC/UPLC mobile phase adjustment)
Pharmaceutical Formulation
Preferred for:
- Protein stabilization in lyophilized preparations
- Ophthalmic solutions requiring alkaline pH maintenance
- Transdermal delivery systems
3. Protocol Implementation & Case Studies
Case Study 1: Western Blot Optimization
Protocol: 25mM CAPS buffer with 20% methanol, pH 11.0
Result: 98% transfer efficiency for 150kDa proteins
Advantage: Reduced transfer time from 16hrs to 45min vs. traditional buffers
Case Study 2: Nanoparticle Synthesis
Application: Gold nanoparticle stabilization
Concentration: 50mM CAPS, pH 10.5
Outcome: 20nm particles with ±1.2nm size distribution
4. Industry-Specific Implementation Examples
| Industry | Application | Typical Concentration |
|---|---|---|
| Diagnostics | ELISA wash buffers | 10-25mM |
| Biopharma | Monoclonal antibody purification | 50mM |
5. Verified Client Success Stories
Client 1: European Biotech Leader
Challenge: Protein degradation in downstream processing
Solution: 40mM CAPS buffer in purification steps
Outcome: 30% yield improvement, 99.2% purity
Client 2: Asian Pharma Manufacturer
Issue: Unstable vaccine formulation
Implementation: CAPS-based lyoprotectant system
Result: 24-month stability at 2-8°C
6. Expert Consultation & Sample Request
Contact our technical specialists for:
- Custom buffer formulation assistance
- Application-specific protocol development
- Bulk order specifications (GMP-grade available)
Email: info@vivalr.com
Phone: (86) 15866781826
Request product datasheet: [Your Name] [Company] [Application Details]



评论
目前还没有评论。